Somatostatinoma syndrome: does a clinical entity exist?

in European Journal of Endocrinology
Authors:
Peter W. Stacpoole
Search for other papers by Peter W. Stacpoole in
Current site
Google Scholar
PubMed
Close
,
A. G. Kasselberg
Search for other papers by A. G. Kasselberg in
Current site
Google Scholar
PubMed
Close
,
Michael Berelowitz
Search for other papers by Michael Berelowitz in
Current site
Google Scholar
PubMed
Close
, and
William Y. Chey
Search for other papers by William Y. Chey in
Current site
Google Scholar
PubMed
Close
Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

Abstract.

We report here 2 patients with somatostatinsecreting tumours and hypersomatostatinaemia. One subject, a 36 year old woman with diabetes, flushing, labile blood pressure and diarrhoea, had elevated basal plasma levels of somatostatin-like immunoreactivity (SLIR) and calcitonin. Plasma SLIR increased further following tolbutamide administration. Plasma levels of prostaglandin E2 (PGE2) and pancreatic polypeptide (PP), normal in the basal state, showed exaggerated responses to pentagastrin and secretin, respectively. Immunocytochemistry of the tumour tissue revealed cells containing somatostatin-, calcitonin-, PGE2- and PP-like immunoreactivity. The other patient, a 52 year old male, had an SLIR-secreting tumour of the proximal duodenum and elevated basal and post-tolbutamide SLIR levels but no signs or symptoms suggestive of increased SLIR production. Tumour tissue revealed cells containing somatostatin- and calcitonin-like immunoreactivity.

We conclude that patients with somatostatinomas do not always exhibit a predictable syndrome. Patients with these tumours may exhibit a range of clinical, biochemical and immunocytochemical features typical of endocrine tumours of mixed-cell origin, such that the dominant signs and symptoms associated with these neoplasms cannot readily be ascribed to overproduction of any single hormone.

 

  • Collapse
  • Expand

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 31 31 9
Full Text Views 0 0 0
PDF Downloads 0 0 0